The overall objective of this proposal is to continue to investigate cellular, molecular, and electrophysiologic mechanisms by which retinoids induce the differentiation and modulate the immunocompetence of human lymphocytes.
The first aim i s to determine the T-cell spectrum of action and mechanism by which retinoic acid (RA) regulates IL-2-receptor (IL-2R) expression on T lymphoblasts. Our previous studies with thymocyte blasts have led us to speculate that T-cell responses to RA are dependent upon suboptimal IL-2 utilization. Experiments have been designed to address this question as well as to delineate the level of regulation by which RA affects IL-2R gene expression.
The second aim of this project is to establish role for ion channels in early """"""""triggering"""""""" events in RA immunomodulation of human B-cell hybridomas. These electrophysiological investigations will utilize the """"""""patch-clamp"""""""" methodology and focus on two fundamental questions: 1) Does RA modulate ion (Ca) channels in the hybridoma cells? 2) Is the ability of RA to alter ion channels involved in its differentiation-inducing activity. Results obtained will provide basic information concerning the role of ion channels and ion fluxes in the immunoregulatory processes of B cells. Thirdly, we propose to expand our studies of retinoid effects on human B cells by delineating the interrelationship between RA immune modulation and normal developmental drives. Based upon our work with T lymphocytes, it is our hypothesis that RA does not act as a direct differentiation drive on B cells, but rather alters their sensitivity to norm a1 developmental signals/growth factors. This hypothesis will be tested by assessing the effects of RA along with various activation growth signals on the differentiation and the secretion from fresh tonsil lymphocytes. Results obtained will be complementary to the more basic ion-related questions that are being addressed with the B-cell hybridomas. Finally, we will delineate the cellular mechanism of action of in vivo 13-cis RA therapy to enhance responses to defined antigens (KLH and tetanus) using patient materials generated during the past funding period. Initial studies indicate a significant retinoid induced enhancement of secondary anti-KLH antibody responses to suboptimal immunizing doses of KLH. Using a variety of in vitro assays, we will discern the T- and B-cell contributions of this effect as well as the retinoid-sensitive phase of the immunization process. This study will, for the first time in humans, characterize the modulation of antigen-specific immune responses by in vivo administration of a retinoid.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA030515-09
Application #
3169285
Study Section
Experimental Immunology Study Section (EI)
Project Start
1982-08-01
Project End
1993-12-31
Budget Start
1991-01-01
Budget End
1991-12-31
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Connor, M J; Sidell, N (1997) Retinoic acid synthesis in normal and Alzheimer diseased brain and human neural cells. Mol Chem Neuropathol 30:239-52
Han, G; Chang, B; Connor, M J et al. (1995) Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells. Differentiation 59:61-9
Saxon, A; Keld, B; Diaz-Sanchez, D et al. (1995) B cells from a distinct subset of patients with common variable immunodeficiency (CVID) have increased CD95 (Apo-1/fas), diminished CD38 expression, and undergo enhanced apoptosis. Clin Exp Immunol 102:17-25
Saxon, A; Max, E E; Diaz-Sanchez, D et al. (1995) Alternative RNA of epsilon transcripts produces mRNAs encoding two membrane and four secreted IgE isoforms. Int Arch Allergy Immunol 107:45-7
Sidell, N; Wada, R; Han, G et al. (1995) Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells. Int J Cancer 60:507-14
Zhang, K; Max, E E; Cheah, H K et al. (1994) Complex alternative RNA splicing of epsilon-immunoglobulin transcripts produces mRNAs encoding four potential secreted protein isoforms. J Biol Chem 269:456-62
Wuarin, L; Chang, B; Wada, R et al. (1994) Retinoic acid up-regulates nuclear retinoic acid receptor-alpha expression in human neuroblastoma cells. Int J Cancer 56:840-5
Bhatti, L; Sidell, N (1994) Transcriptional regulation by retinoic acid of interleukin-2 alpha receptors in human B cells. Immunology 81:273-9
Sidell, N; Chang, B; Bhatti, L (1993) Upregulation by retinoic acid of interleukin-2-receptor mRNA in human T lymphocytes. Cell Immunol 146:28-37
Saxon, A; Keld, B; Braun, J et al. (1993) Long-term administration of 13-cis retinoic acid in common variable immunodeficiency: circulating interleukin-6 levels, B-cell surface molecule display, and in vitro and in vivo B-cell antibody production. Immunology 80:477-87

Showing the most recent 10 out of 32 publications